Observational analysis shows improved sleep monitoring in diverse populations, highlighting the potential of BCG technology.
Sleep profoundly impacts health, yet current gold‐standard Polysomnogram (PSG) is constrained by cost, discomfort, and limited scalability for longitudinal monitoring. Ballistocardiogram (BCG) offers a non-invasive and user-friendly alternative but often lacks the precision needed for reliable real-world applications. To address this gap, we propose BCGNet, a two-stage transfer learning model that is first pre-trained on 580,866 hours of PSG and then fine-tuned and validated on 15,081 hours of BCG (total 595,947 hours of recordings). Across multiple validation cohorts, BCGNet achieves strong performance in 4-class sleep staging (F1: 0.710-0.817), Apnea-Hypopnea Index (AHI) estimation (Pearson's r>0.95), and robust quantification of sleep continuity and architecture (ICC and Pearson's r generally >0.8). Notably, BCGNet maintains strong performance even on short daytime naps and demonstrates excellent generalizability across diverse external datasets. Deployed as a portable, contactless sleep tracking mat, BCGNet represents a major step towards scalable, user-friendly solutions for longitudinal home sleep monitoring, with important implications for population screening and personalized sleep medicine.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: